T. Lacornerie, X. Mirabel, and E. Lartigau, The CyberKnife: Experience of centre OSCAR-Lambret, Cancer Radiother, vol.13, pp.391-398, 2009.

M. Høyer, A. Swaminath, and S. Bydder, Radiotherapy for liver metastases: A review of evidence, Int J Radiat Oncol Biol Phys, vol.82, pp.1047-1057, 2012.

G. Ambrosino, F. Polistina, and G. Costantin, Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: Preliminary results, Anticancer Res, vol.29, pp.3381-3384, 2009.

C. Vautravers-dewas, S. Dewas, and F. Bonodeau, Image-guided robotic stereotactic body radiation therapy for liver metastases: Is there a dose response relationship?, Int J Radiat Oncol Biol Phys, vol.81, pp.39-47, 2011.

M. S. Kress, B. T. Collins, and S. P. Collins, Stereotactic body radiation therapy for liver metastases from colorectal cancer: Analysis of safety, feasibility, and early outcomes, Front Oncol, vol.2, p.8, 2012.

R. Lanciano, J. Lamond, and J. Yang, Stereotactic body radiation therapy for patients with heavily pretreated liver metastases and liver tumors, Front Oncol, vol.2, p.23, 2012.

E. A. Eisenhauer, P. Therasse, and J. Bogaerts, New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), Eur J Cancer, vol.45, pp.228-247, 2009.

R. S. Benjamin, H. Choi, and H. A. Macapinlac, We should desist using RECIST, at least in GIST, J Clin Oncol, vol.25, pp.1760-1764, 2007.

H. Choi, Response evaluation of gastrointestinal stromal tumors, Oncologist, vol.13, pp.4-7, 2007.

J. Shindoh, Y. S. Chun, and E. M. Loyer, Non-size-based response criteria to preoperative chemotherapy in patients with colorectal liver metastases: The morphologic response criteria, Curr Colorectal Cancer Rep, vol.9, pp.198-202, 2013.

N. E. Dunlap, W. Yang, and A. Mcintosh, Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer, Int J Radiat Oncol Biol Phys, vol.84, pp.1071-1077, 2012.

T. De-baere, Ablation of liver metastases by radiofrequency, Cancer Radiother, vol.16, pp.339-343, 2012.

T. R. Price, S. M. Perkins, and K. Sandrasegaran, Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma, Cancer, vol.118, pp.3191-3198, 2012.

R. L. Wahl, H. Jacene, Y. Kasamon, and M. A. Lodge, From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors, J Nucl Med, vol.50, pp.122-150, 2009.

R. García-figueiras, V. J. Goh, and A. R. Padhani, CT perfusion in oncologic imaging: A useful tool?, AJR Am J Roentgenol, vol.200, pp.8-19, 2013.

S. P. Li and A. R. Padhani, Tumor response assessments with diffusion and perfusion MRI, J Magn Reson Imaging, vol.35, pp.745-763, 2012.

F. L. Giesel, S. Wulfert, and C. M. Zechmann, Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177Lu/90Y-DOTATOC and 213Bi-DOTATOC radiopeptide therapy, Exp Oncol, vol.35, pp.122-126, 2013.

H. Jarraya, X. Mirabel, and S. Taieb, Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking, Radiat Oncol, vol.8, p.24, 2013.

M. T. Lee, J. J. Kim, and R. Dinniwell, Phase I study of individualized stereotactic body radiotherapy of liver metastases, J Clin Oncol, vol.27, pp.1585-1591, 2009.

S. Dewas, X. Mirabel, and A. Kramar, Stereotactic body radiation therapy for liver primary and metastases: The Lille experience, Cancer Radiother, vol.16, pp.58-69, 2012.

J. Kalkmann, M. Zeile, and G. Antoch, Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): Recommendations of the German GIST Imaging Working Group, Cancer Imaging, vol.12, pp.126-135, 2012.

C. Y. Wong, R. Salem, and S. Raman, Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F] FDG PET: A comparison with CT or MRI, Eur J Nucl Med Mol Imaging, vol.29, pp.815-820, 2002.

K. E. Rusthoven, B. D. Kavanagh, and H. Cardenes, Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases, J Clin Oncol, vol.27, pp.1572-1578, 2009.

R. Cirocchi, S. Trastulli, and C. Boselli, Radiofrequency ablation in the treatment of liver metastases from colorectal cancer, Cochrane Database Syst Rev, vol.6, p.6317, 2012.

S. P. Li, A. R. Padhani, and A. Makris, Dynamic contrast-enhanced magnetic resonance imaging and blood oxygenation level-dependent magnetic resonance imaging for the assessment of changes in tumor biology with treatment, J Natl Cancer Inst Monogr, vol.43, pp.103-107, 2011.

A. R. Padhani and A. A. Khan, Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy, Target Oncol, vol.5, pp.39-52, 2010.

H. Wang, R. Farjam, and M. Feng, Arterial perfusion imaging: Defined subvolume of intrahepatic cancer, Int J Radiat Oncol Biol Phys, vol.89, pp.167-174, 2014.

D. T. Chang, A. Swaminath, and M. Kozak, Stereotactic body radiotherapy for colorectal liver metastases: A pooled analysis, Cancer, vol.117, pp.4060-4069, 2011.